BIONTECH really tight long setupI love tight jeans on my gf, but this setup is tighter as tight.
Pt´s at around 220-230ish
22UA trade ideas
Descending wedgeBNTX looks to be in a descending wedge and coming to its peak.
I have highlighted the red line horizontal resistance levels to watch in the event of a breakout.
Orange lines are the nPOC levels of interest.
Green line should be major support area at 120.
Descending wedge PT would be top of wedge.
no description neededno description needed no description needed no description needed no description needed no description needed no description needed no description needed no description neededno description needed no description needed no description needed no description needed no description needed no description needed no description needed no description neededno description needed no description needed no description needed no description needed no description needed no description needed no description needed no description needed
potential dip entries here🚀bntx is approaching extreme support here, a couple outcomes can happen.
we either bounce here and test top trendline before pullback, or we test the bottom of extreme support range first.
Both are profitable outcomes if you play it right, like and follow for more 💘
$BNTX; trading it 1/3 For 1/3, intraday trading ideas for options trading; not financial advice, 2 plans for red or green market day.
Break over 264 (entry, long), it can see 275-282 (exit)
Break below 251 (entry, short), it can see 233-240 (exit)
#options #daytrading
Option Trading 101:
Risk what you can lose (0.5%-5%)
Watch buyers and sellers (their interactions & sentiment, ex. exhaustion of buying or selling, etc.) in strikes that you’re watching & the ticker too; this is how YOU manage YOUR trade.
Consider following and checking out my prior posts, have a great one.
Biontech in an interesting spotBiontech seems to be at a critical point and repeating a couple of previous runs.
Pattern will be more defined by next week whether that run would happen or not.
Biontech Analysis 22.12.2021Hello Traders,
welcome to this free and educational analysis.
I am going to explain where I think this asset is going to go over the next few days and weeks and where I would look for trading opportunities.
If you have any questions or suggestions which asset I should analyse tomorrow, please leave a comment below.
I will personally reply to every single comment!
If you enjoyed this analysis, I would definitely appreciate it, if you smash that like button and maybe consider following my channel.
Thank you for watching and I will see you tomorrow!
BNTX LONG +5, +30 +150 % channelI will buy Biontech after breaking through the turquoise bold line. In doing so, I will set a short stop lose at 0.4% below this line and will raise it over time. Next, I plan to buy after the next thin turquoise line is broken, if the indicators favor buying.
This is not a financial recommendation.
Take care.
$BNTX flier into next week...Looking for some COVID plays to both sides, looking at a $400/$450 call spread at $1.95, paired with a $270 put if there is news that the new variant is less deadly over the weekend.
$BNTX^ $BNTX will announce if its possible to revise their current vaccine to accommodate the new strain in 2 weeks and could redesign its vaccine within 6 weeks, with an aim to distribute it within 100 days.
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is involved in the developing of FixVac product candidates, including BNT111, which is in Phase I clinical trial for advance melanoma; BNT112 that is in Phase I/IIa trial for prostate cancer; BNT113, which is in Phase I/II trial to treat HPV+ head and neck cancers; BNT114 that is in Phase I clinical trial for triple negative breast cancer; BNT115 in a Phase I trial in ovarian cancer; and BNT116 for non-small cell lung cancer.It also develops neoantigen specific immunotherapies, such as Autogene cevumeran (BNT122), which is in Phase II clinical trial for first-line melanoma, as well as in Phase I clinical trial to treat multiple solid tumors; mRNA intratumoral immunotherapy comprising SAR441000 that is in Phase I clinical trial for solid tumors; and BNT141 and BNT142 to treat multiple solid tumors. In addition, the company develops RiboCytokines, which include BNT151, BNT152, and BNT153 for multiple solid tumors; chimeric antigen receptor T cell immunotherapies, such as BNT211 to treat multiple solid tumors, and BNT221 for other cancers; and checkpoint immunomodulators consisting of GEN1046 and GEN1042, which are in Phase I/II a clinical trial to treat multiple solid tumors. Further, it develops BNT321, an IgG1 monoclonal antibody, which is in Phase I/IIa clinical trial for pancreatic cancer; BNT411, small molecule immunomodulator product candidate for solid tumors; prophylactic vaccine for COVID-19 and Influenza; and infectious disease immunotherapies and rare disease protein replacement therapies. The company has collaborations with Genentech, Inc.; Sanofi S.A.; Genmab A/S; Genevant Sciences GmbH; Pfizer Inc.; Shanghai Fosun Pharmaceutical (Group) Co., Ltd.; and Regeneron Pharmaceuticals, Inc. BioNTech SE was incorporated in 2008 and is headquartered in Mainz, Germany.
Long BNTX Call OptionsBNTX appears to be breaking out on news from Europe in relation to COVID. Governments such as Austria are taking a much harder line and this should significantly increase demand (initial doses plus boosters).
Bought two sets of call options - Dec/17 and short term breakout Nov/26.
BNTX massive breakBreak is happening today, Could take it today or wait for an extra candle, I might wait
But chart looks pretty good
$BNTX Due for an Oversold Bounce (bat pattern)2 day Candles here, I will be looking to enter early if i see a volume signature in Tc2k in low tf, i will update as well
Huge growth here //Covid Profits #'s below in Koyfin
app.koyfin.com
BIONTECH - 4,60% Potential?! - maybe TREND REVERSAL?The pandemic is at it`s peak in many countries, and biontech has great newsflow right now - maybe we could see a breakout of the downtrend channel.
I will not close my trade yet, because even in the downtrend channel i still see some upward potential (4,60%) - if it hits my target I will close my position but keep in mind that it still can break that channel.
$BNTX BioNTech SE LONG Trade Setup$BNTX BioNTech got wrecked since its August high and lost over 50% of its value.
BNTX is at it's 200 day moving average, if that holds as support, it is a very nice swingtrade setup.
With Covid numbers rising all across the world and booster vaccines for everybody getting more and more a thing,
BNTX could possibly go on another bullrun cycle.
Approach with caution though, that stock can get wild in both directions.
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
